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Orth.otopic Liver Transplant a Case Report
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We describe a case of giant cavernous haemangioma of the liver with disseminated intravascular
coagulopathy (Kasabach-Merritt syndrome) which was cured by orthotopic liver transplant.
A 47 year old man presented with bleeding and tender massive hepatomegaly after tooth extraction.
Investigations showed disseminated intravascular coagulopathy and a giant hepatic haemangioma involv-
ing both lobes of the liver. Initial treatment failed to resolve the coagulopathy and liver resection was
attempted. At laparotomy the turnout was unresectable and the only option for cure was to offer a liver
transplantation. The orthotopic liver transplant was performed 20 days after initial laparotomy. Subse-
quently, all coagulation parameters returned to normal and the patient remains well after 12 months.
Orthotopic liver transplant can be considered for giant hepatic haemangioma with Kasabach-Merritt
syndrome when resection is necessary and a partial hepatectomy is not technically feasible.
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INTRODUCTION
Cavernous haemangioma is the most common benign
tumour ofthe liver and is usually solitary and less than
4 cm in diameter. Giant hepatic haemangioma is
uncommon, rarely causes symptoms and requires no
specific treatment when asymptomatic.
The Kasabach-Merritt syndrome (KMS) describes
the occurence of disseminated intravascular coagulo-
pathy (DIC) with a large haemangioma and was first
observed in association with a cutaneous haeman-
gioma. The natural course of the disease is character-
ised by a life-threatening coagulopathy. Treatment of
this syndrome is often difficult, but resection of the
tumour, when feasible, is usually curative.
Correspondence to: Dr. RTA Padbury, Department of Surgery,
Flinders Medical Centre, Bedford Park, 5042, Adelaide, South
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Only one case of orthotopic liver transplant (OLT)
for an unresectable hepatic haemangioma has been
previously described. We report a second case of
successfulOLT forKMS with complete reversal ofthe
coagulopathy postoperatively.
CASE REPORT
A 47 year old man was referred to hospital for exces-
sive bleeding after wisdom teeth extraction. His past
and family history were unremarkable. On examina-
tion the patient was pale with obvious bleeding from
the gum sockets and extensive bruising of the face.
Abdominal examination revealed a tender massive
hepatomegaly. Serial coagulation studies demons-
trated a disseminated intravascular coagulopathy.
Prothrombin time (PT) and activated partial
thromboplastin time (APTT) were slightly prolonged
at 17 sec (control: 11 sec) and 37 sec (control: 31
sec) respectively. The platelet count (95 103/tl; n:
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150450 x 103/[.tl) and fibrinogen (0.6 gr/1; n: 2-4.5 gr/
1) were low and the XL-fibrinogen degradation products
(XL-FDP) were significantly elevated at 4-8 gr/1
(n<0.25 gr/1). The Euglobin lysis time was greater
than 90 mins. The antithrombin 3 plasma level was
low at 69% (Normal range: 79%-120%.). The leuco-
cyte and red blood cell counts were within the normal
range.
Abdominal CT scan revealed an exophytic tumour,
25 cm in diameter, replacing the left lobe and invading
the right lobe ofthe liver, and extending inferiorly into
the pelvis Figure 1. Following contrast, the periphery
of the mass strongly enhanced and delayed scans
showed filling from the periphery to the centre of the
mass. A second 4 cm tumour suggestive of haeman-
gioma was also seen in the posterior sector of the right
lobe. A 99mTc red cells scan of liver confirmed the
diagnosis of haemangioma.
The patient was treated with low dose i.v. heparin
(500 IU/h) and received multiple cryoprecipitate
transfusions. Packing of the oral bleeding areas as-
sisted with the control of the haemorrhage. Heparin
therapy and cryoprecipitate transfusion resulted in a
slight increase of fibrinogen levels and control of the
DIC, but failed to improve the platelet count. Con-
tinuing heparin administration was necessary to main-
tain fibrinogen levels. To correct the coagulopathy,
the decision was taken to proceed to surgical removal
of the larger haemangioma.
The heparin infusion was ceased 2 hours prior to
laparotomy and in total 40 units of cryoprecipitate
had been administered preoperatively. During initial
laparotomy, the tumour was found to be extending
extensively towards the right lobe of the liver (which
was compressed by the large bulk of the tumour)
with an absence of a clear peritumoral capsule on
the intraoperative ultrasound (and subsequently
confirmed by histopathology). Furthermore, the ul-
trasound appearances suggested that the margins of
the lesion surrounded the right hepatic vein, thereby
rendering resection impossible. Neither the
preoperative CT scan nor the intraoperative ultra-
sound identified a right subhepatic vein, the presence
of which may have rendered the haemangioma
resectable.
After the initial surgical assessment, it was consid-
ered that the only therapeutic option which might
achieve cure was a liver transplantation.
Figure 1 CT scan section demonstrating the close relationship between the cavernous haemangioma and the right hepatic vein
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While awaiting liver transplantation the DIC per-
sisted and heparinisation remained necessary. OLT
was performed 20 days after the exploratory
laparotomy. The heparin infusion was ceased
approximately 4 hours prior to the induction
of anaesthesia. Following anaesthetic induction
an aprotinin (Trasylol(R), Bayer, Pymble, Australia)
infusion was commenced (2x 106 KI units loading dose
followed by a 5x105 KI units/hour continuous
infusion). A femoral bypass cannula was inserted
percutaneously prior to commencement ofabdominal
procedure. Rapid clotting ofthe femoral cannula after
insertion precluded the use of bypass and it was de-
cided to cease the aprotinin infusion.
The OLT procedure was a standard piggy-back
technique. Total operating time was 9 hours and the
total ischaemic time of the donor liver was 12 hours.
The patient received a total of 14 units of blood, 16
units offresh frozen plasma, 17 units ofplatelets and 2
units of cryoprecipitate during the procedure.
The recipient hepatectomy was a difficult procedure
because of the bulk and weight of the tumour. Access
to the hepatic pedicle was restricted and to gain expo-
sure to control haemorrhage the pedicle was mass
clamped and divided.
With further manipulation the haemangioma pro-
gressively emptied, became significantly smaller, and
the surgical exposure improved.
The patient did not receive heparin nor aprotinin
infusions postoperatively. The early postoperative
course was marked by an intraabdominal haemor-
rhage. The patient was returned to theatre and the
only site of haemmorrhage was from divided liga-
ments on the right side of the donor liver. The subse-
quent recovery was uneventful. Complete correction
of coagulation parameters was achieved within 24
hours post-transplantation. The PT and APTT
were normal within 12 hours of removal of the
haemangioma. There was a dramatic fall in the XL-
FDP levels within 24 hours. The patient remains well
and symptomless 12 months after the procedure.
The liver weighted 3570 gr; the entire left lobe and a
portion of the adjacent right lobe were replaced by a
giant cavernous haemangioma Figure 2. A separate
subcapsular haemangioma, maximum diameter 35
mm, was also present in the right lobe. The main
tumour was poorly encapsulated and sections from
the right lobe of the liver adjacent to the tumour
showed focal areas of cavernous haemangioma inter-
mingled with normal liver Figure 3. Multiple old and
recent thrombi were seen within the haemangioma.
Figure 2 "Native" liver showing complete replacement of the left
lobe by a giant haemangioma. The turnout also involves the medial
aspect of the right lobe.
Figure 3 Section of the right lobe of liver, taken some distance
from the main tumour mass, showing one of the separate small
cavernous haemangioma. Normal hepatic parenchyma surrounds
the collection of thin-walled blood vessels. H&E x 110.
DISCUSSION
The vast majority of hepatic cavernous haeman-
giomas remain asymptomatic and are discovered inci-
dentally. Rarely, a large haemangioma may cause
right upper quadrant pain, but the potential for rup-
ture is negligible and does not in itself constitute an
indication for resection. Malignant transformation is
unknown.
KMS is a consumptive coagulopathy described origi-
nally in association with cutaneous haemangiomas in
children. This coagulopathy is thought to be related to
a localised formofintravascular coagulation within the
haemangioma. KMS associated with hepatic haeman-
giomas is rare, but well-known, and raises a number of
management problems.162 J-H. LONGEVILLE et al.
There have been several reports of the use of low
dose heparin infusion, cryoprecipitate and aminoca-
proic acid to control the intravascular coagu-
lopathy.9’1 In our case heparinisation decreased the
DIC but failed to cure completely the coagulopathy.
Removal of the tumour was required, and partial
hepatectomy, if technically feasible, was considered a
superior option to OLT in the first instance. The pres-
ence of the second, considerably smaller, haeman-
gioma in the right lobe of the liver was not considered
a contraindication to attempt partial hepatectomy as
KMS does not occur in association with small hae-
mangiomas. There have been a variety of surgical
techniques advocated to resect hepatic cavernous hae-
mangiomas. Most authors advocate formal fiver resection.
Alternatively, there have been reports of "enuclea-
tion" of the tumour following a cleavage plane sepa-
rating the fibrous capsule ofthe tumour and the normal
liver parenchyma.
11 In our case, the extension of the
tumour towards the right liver with involvement of the
right hepatic vein, and the absence of a peritumoral
capsule, precluded the possibility of limited hepatic
resection or enucleation during the first laparotomy.
The presence of an ongoing coagulopathy raised
technical problems during the OLT. Because of
the improvement of the DIC and a concern about
intraoperative and postoperative bleeding the low dose
heparin infusion was stopped before the OLT. This
heparin-free period was associated with decreased
fibrinogen and increased FDP. The rapid clotting of
the femoral cannula at the beginning ofthe procedure,
in conjunction with the preoperative abnormal anti-
thrombin levels, raised further concern about con-
comitant hypercoagulability and the aprotinin
infusion was ceased. In retrospect, it may have been
optimal to continue heparin until the end of the
hepatectomy to control the DIC and to prevent the
clotting of the venous accesses.
OLTcan be performed safely in gianthaemangiomata
complicated by KMS when resection is necessary but
technically impossible.
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